Duke Offshore Limited (BOM:531471)

India flag India · Delayed Price · Currency is INR
16.15
-0.08 (-0.49%)
At close: Jul 29, 2025

Verve Therapeutics Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
-21.9812.39-4.49-41.07-19.68
Upgrade
Depreciation & Amortization
4.658.948.9418.1913.68
Upgrade
Loss (Gain) From Sale of Assets
3.21----
Upgrade
Asset Writedown & Restructuring Costs
---8.64-
Upgrade
Other Operating Activities
11.6-26.88-8.111.860.33
Upgrade
Change in Accounts Receivable
---1.89-4.791.93
Upgrade
Change in Accounts Payable
0.340.220.22-0.68-0.75
Upgrade
Change in Other Net Operating Assets
-1.26.486.48-5.350.63
Upgrade
Operating Cash Flow
-3.391.151.15-23.21-3.85
Upgrade
Capital Expenditures
-0.03-2.41-2.41-4.84-1.68
Upgrade
Sale of Property, Plant & Equipment
0.45----
Upgrade
Investment in Securities
-1.45----
Upgrade
Other Investing Activities
00.050.050.332.14
Upgrade
Investing Cash Flow
-1.02-2.36-2.36-4.520.46
Upgrade
Long-Term Debt Issued
1.61----
Upgrade
Long-Term Debt Repaid
-1.66-1.46-1.46-1.34-1.24
Upgrade
Total Debt Repaid
-1.66-1.46-1.46-1.34-1.24
Upgrade
Net Debt Issued (Repaid)
-0.05-1.46-1.46-1.34-1.24
Upgrade
Other Financing Activities
-0.09-0.35-0.35-0.54-0.6
Upgrade
Financing Cash Flow
-0.14-1.81-1.81-1.89-1.84
Upgrade
Miscellaneous Cash Flow Adjustments
----0
Upgrade
Net Cash Flow
-4.55-3.02-3.02-29.61-5.23
Upgrade
Free Cash Flow
-3.42-1.25-1.25-28.05-5.53
Upgrade
Free Cash Flow Margin
-493.07%-3.03%-4.51%-192.35%-33.22%
Upgrade
Free Cash Flow Per Share
-0.35-0.13-0.13-2.85-0.56
Upgrade
Cash Interest Paid
0.090.350.350.540.6
Upgrade
Cash Income Tax Paid
-0.580.230.230.2-4.58
Upgrade
Levered Free Cash Flow
-2.735.783.08-22.32.55
Upgrade
Unlevered Free Cash Flow
-2.675.943.3-21.962.92
Upgrade
Change in Net Working Capital
-10.553.04-4.5811.03-5.86
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.